Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoTo-HEM
NCT07399860Phase 2Recruiting
- Sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Start
- Feb 2026
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Preoperative Botulinum Toxin A Injection with Preoperative Placebo Injection (2 arms). Primary endpoint: Postoperative Pain Intensity Within the First 7 Days After Hemorrhoidectomy. Started Feb 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07399860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07399860.